Skip to main content
. 2011 Jan 5;84(1):78–84. doi: 10.4269/ajtmh.2011.10-0177

Table 2.

TSSA-WB and CS co-reactivity of samples from Latin American patients

Sample origin TSSA I/TSSA II vs. CS
Co-positivity (%) Co-negativity (%)
Mexico 36.1 78.0
Colombia 62.0 63.4
Venezuela 42.7 82.0
Argentina 97.1 100.0
Paraguay 93.0 71.4

Co-positivity = 100 × (frequency of TSSA-WB reactive samples/frequency of CS positive samples). Co-negativity = 100 × (frequency of TSSA-WB unreactive samples/frequency of CS negative samples).